SCNI (Scinai Immunotherapeutics Ltd. American Depositary Shares) Stock Analysis - AI Report
Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) is a publicly traded Healthcare sector company. As of May 20, 2026, SCNI trades at $0.48 with a market cap of $2.22M and a P/E ratio of 0.00. SCNI moved -3.56% today. Year to date, SCNI is -30.35%; over the trailing twelve months it is -81.98%. Its 52-week range spans $0.45 to $6.18. Rallies surfaces SCNI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on SCNI?
Rallies AI research for SCNI combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
BEATY ELWIN M bought 80.00K (~$5.20K) on Dec 14, 2007.
BEATY ELAINE E bought 80.00K (~$5.20K) on Dec 14, 2007.
BEATY ELWIN M sold 80.00K (~$5.20K) on Dec 14, 2007.
SCNI Analyst Consensus
SCNI analyst coverage data. Average price target: $0.00.
Common questions about SCNI
What is the AI research view on SCNI?
Rallies AI research for SCNI combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for SCNI?
Rallies AI research for SCNI combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is SCNI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SCNI. It does not provide personalized investment advice.